ARCHIVES

NCI Director asks NCAB to pray for him.

This article is from The Cancer Letter archive.

Vol. 30 No. 25 | June 18, 2004

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 11 Issue 2, Summer 1997

June 13, 1997

Competing Core, P01 Grants Held To 7% Increases To Help Spread $$ Around

December 7, 1979

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008

Three Studies Demonstrate Oncotype DX Test Effectiveness

March 30, 2012

NSABP Disputed NCI Cost Estimate For P-4 Trial.

May 25, 2007

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976